Multiple Sclerosis
MS Briefs
MS: Breastfeeding May Offer Protection Against Postpartum Relapse
News
First generics for Gilenya approved by FDA
Approvals for fingolimod generics were issued to three companies.
MS Briefs
When Can Cognitive Decline Be Predicted After MS Diagnosis?
MS Briefs
Comboridies Adversely Impact Cognition in MS
MS Briefs
Is FOXP3 Gene Polymorphism a Risk for MS?
Conference Coverage
Late-onset MS is often more severe than earlier-onset MS
ST. LOUIS – Late-onset MS often has faster accrual of disability and might require different treatment options.
MS Briefs
Time to Disability Milestones in MS Is Lengthening
MS Briefs
From DMTs to Secondary Progressive MS
Conference Coverage
MS-related disability may be decreasing
STOCKHOLM – International data indicate that the prognosis of MS has improved, partly as a result of treatment.